214 related articles for article (PubMed ID: 7564268)
1. Induction of atypical hyperplasia, apoptosis, and type II estrogen-binding sites in the ventral prostates of Noble rats treated with testosterone and pharmacologic doses of estradiol-17 beta.
Ho SM; Leav I; Merk FB; Yu M; Kwan PW; Ziar J
Lab Invest; 1995 Sep; 73(3):356-65. PubMed ID: 7564268
[TBL] [Abstract][Full Text] [Related]
2. Selective increase in type II estrogen-binding sites in the dysplastic dorsolateral prostates of noble rats.
Ho SM; Yu M
Cancer Res; 1993 Feb; 53(3):528-32. PubMed ID: 7678774
[TBL] [Abstract][Full Text] [Related]
3. Early alterations in ras protooncogene mRNA expression in testosterone and estradiol-17 beta induced prostatic dysplasia of noble rats.
Yu M; Leav BA; Leav I; Merk FB; Wolfe HJ; Ho SM
Lab Invest; 1993 Jan; 68(1):33-44. PubMed ID: 8423674
[TBL] [Abstract][Full Text] [Related]
4. Expression and regulation of metallothionein mRNA levels in the prostates of noble rats: lack of expression in the ventral prostate and regulation by sex hormones in the dorsolateral prostate.
Ghatak S; Oliveria P; Kaplan P; Ho SM
Prostate; 1996 Aug; 29(2):91-100. PubMed ID: 8700805
[TBL] [Abstract][Full Text] [Related]
5. Hormonal regulation of nuclear type II estrogen binding sites in the dorsolateral prostate of noble rats.
Ho SM; Yu M
J Steroid Biochem Mol Biol; 1995 Mar; 52(3):233-8. PubMed ID: 7696144
[TBL] [Abstract][Full Text] [Related]
6. Androgen- and estrogen-receptor content in spontaneous and experimentally induced canine prostatic hyperplasia.
Trachtenberg J; Hicks LL; Walsh PC
J Clin Invest; 1980 May; 65(5):1051-9. PubMed ID: 6154062
[TBL] [Abstract][Full Text] [Related]
7. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
[TBL] [Abstract][Full Text] [Related]
8. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
[TBL] [Abstract][Full Text] [Related]
9. Ultrastructural and biochemical expressions of divergent differentiation in prostates of castrated dogs treated with estrogen and androgen.
Merk FB; Ofner P; Kwan PW; Leav I; Vena RL
Lab Invest; 1982 Nov; 47(5):437-50. PubMed ID: 6182388
[TBL] [Abstract][Full Text] [Related]
10. New histopathological experimental model for benign prostatic hyperplasia: stromal hyperplasia in rats.
Mori F; Oda N; Sakuragi M; Sakakibara F; Kiniwa M; Miyoshi K
J Urol; 2009 Feb; 181(2):890-8. PubMed ID: 19095262
[TBL] [Abstract][Full Text] [Related]
11. Effects of testosterone, and testosterone plus estrogen, in the castrated rat ventral prostate--histopathological and immunocytochemical studies.
Murakoshi M; Tagawa M; Inada R; Suzuki M
Tokai J Exp Clin Med; 1992 Oct; 17(3-4):133-7. PubMed ID: 1284451
[TBL] [Abstract][Full Text] [Related]
12. Oral exposure to low-dose bisphenol A aggravates testosterone-induced benign hyperplasia prostate in rats.
Wu JH; Jiang XR; Liu GM; Liu XY; He GL; Sun ZY
Toxicol Ind Health; 2011 Oct; 27(9):810-9. PubMed ID: 21415097
[TBL] [Abstract][Full Text] [Related]
13. Sex hormone-induced alterations in the activities of antioxidant enzymes and lipid peroxidation status in the prostate of Noble rats.
Tam NN; Ghatak S; Ho SM
Prostate; 2003 Apr; 55(1):1-8. PubMed ID: 12640655
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic investigation of the adrenergic induction of ventral prostate hyperplasia in mice.
Marinese D; Patel R; Walden PD
Prostate; 2003 Feb; 54(3):230-7. PubMed ID: 12518328
[TBL] [Abstract][Full Text] [Related]
15. The effect of estrogen supplementation on cell proliferation and expression of c-kit positive cells in the rat prostate.
Kusljic S; Exintaris B
Prostate; 2010 Oct; 70(14):1555-62. PubMed ID: 20687229
[TBL] [Abstract][Full Text] [Related]
16. Sex hormone-induced carcinogenesis in Rb-deficient prostate tissue.
Wang Y; Hayward SW; Donjacour AA; Young P; Jacks T; Sage J; Dahiya R; Cardiff RD; Day ML; Cunha GR
Cancer Res; 2000 Nov; 60(21):6008-17. PubMed ID: 11085521
[TBL] [Abstract][Full Text] [Related]
17. Doxazosin reduces cell proliferation and increases collagen fibers in rat prostatic lobes.
Justulin LA; Delella FK; Felisbino SL
Cell Tissue Res; 2008 Apr; 332(1):171-83. PubMed ID: 18188599
[TBL] [Abstract][Full Text] [Related]
18. Immunolocalization of androgen receptors, estrogen alpha receptors, and estrogen beta receptors in experimentally induced canine prostatic hyperplasia.
Gallardo F; Lloreta J; García F; Moll X; Baró T; González LA; Morote J; Reventos J; Mogas T
J Androl; 2009; 30(3):240-7. PubMed ID: 19136389
[TBL] [Abstract][Full Text] [Related]
19. Biochemical alterations in sex hormone-induced hyperplasia and dysplasia of the dorsolateral prostates of Noble rats.
Leav I; Ho SM; Ofner P; Merk FB; Kwan PW; Damassa D
J Natl Cancer Inst; 1988 Sep; 80(13):1045-53. PubMed ID: 2457709
[TBL] [Abstract][Full Text] [Related]
20. Comparison of histological compositions and apoptosis in canine spontaneous benign prostatic hyperplasia treated with androgen suppressive agents chlormadinone acetate and finasteride.
Shibata Y; Fukabori Y; Ito K; Suzuki K; Yamanaka H
J Urol; 2001 Jan; 165(1):289-93. PubMed ID: 11125427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
